![]() |
市场调查报告书
商品编码
1946360
苯甲酸添加剂市场-全球产业规模、份额、趋势、机会及预测(按应用、销售管道、地区及竞争格局划分,2021-2031年)Benzoic Acid Excipient Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By End Use Application, By Sales Channel, By Region & Competition, 2021-2031F |
||||||
全球苯甲酸添加剂市场预计将从 2025 年的 364,210 吨成长到 2031 年的 467,530 吨,复合年增长率达到 4.25%。
作为药物的关键成分,这种辅料主要在半固态和液体製剂中用作抗菌防腐剂,抑制真菌和细菌的生长,同时也是多种外用和口服药物的pH调节剂和片剂润滑剂。市场成长的主要驱动因素是全球学名药生产的加速,这需要经济高效的防腐解决方案来确保产品在漫长的供应链中的稳定性;此外,皮肤疾病的日益普遍也需要这种化学物质所具有的强效抗真菌特性。
| 市场概览 | |
|---|---|
| 预测期 | 2027-2031 |
| 市场规模:2025年 | 364,210吨 |
| 市场规模:2031年 | 467,530吨 |
| 复合年增长率:2026-2031年 | 4.25% |
| 成长最快的细分市场 | 直销 |
| 最大的市场 | 北美洲 |
儘管存在这些成长要素,但该行业仍面临许多挑战,包括高昂的生产成本和关键製造地的监管压力。製造商必须应对能源价格波动和严格的合规标准,这些因素会对营运效率和定价策略产生负面影响。根据欧洲化学工业理事会(CEFIC)的预测,受高昂的能源成本和监管成本的影响,到2024年,欧洲化学产业的运转率预计将徘徊在75%左右。如此低的运转率利用率凸显了该行业面临的更广泛挑战:如何在资本密集的全球关键化学中间体市场中保持竞争力。
製药业的扩张,尤其是学名药产量的激增,是苯甲酸辅料市场的主要驱动力。随着製药公司在努力满足不断增长的人口医疗需求的同时控製成本,它们越来越依赖成熟且经济的防腐剂来确保製剂的完整性。苯甲酸在此背景下至关重要,并且被广泛用于防止口服液体製剂和注射中的微生物污染。这种生产动能在主要生产中心尤为明显。根据印度品牌股权基金会于2024年8月发布的《製药业报告》,预计印度2024财年的药品出口额将达到279亿美元,这反映出庞大的生产规模需要稳定的高纯度辅料供应。
同时,皮肤病和真菌感染疾病的增加推动了对专用外用软膏和乳霜的需求。苯甲酸在这些应用中用作抑菌剂,通常与水杨酸联合使用,可有效治疗癣和足癣。这种对皮肤治疗的需求推动了皮肤健康专业公司的收入成长,并因此提高了其成分的使用率。例如,根据拜尔斯道夫股份公司(Baiersdorf AG)于2024年2月发布的2023年度报告,其皮肤科业务部门实现了24.0%的有机销售成长,凸显了消费者对治疗性皮肤产品日益增长的需求。为了维持这个生产规模,化学品供应商保持庞大的业务基础。朗盛公司(LANXESS)2024年消费者保护业务的销售额达到23.4亿欧元,也印证了该领域庞大的市场价值。
能源价格波动和严格的监管标准导致生产成本高昂,严重限制了苯甲酸辅料市场的扩张。苯甲酸生产是一个高能耗过程,因此该产业极易受到全球燃料和电力市场波动的影响。由于这些外部经济因素导致营运成本上升,製造商往往难以维持具有竞争力的价格策略,而这对学名药产业至关重要。因此,生产商可能被迫减少产量或推迟产能扩张以维持利润率,从而直接限制了这种对药物製剂至关重要的防腐剂的供应。
这些成本压力所带来的影响在主要化学製造地区的工业生产下滑中显而易见。成本上升的环境限制了供应商轻鬆扩大生产规模以满足不断增长的需求的能力。根据美国化学理事会(ACC)预测,由于生产商閒置产能以应对高库存和营运成本,预计2023年美国基础化学品产量将下降2.5%。整个化学产业的萎缩直接反映了苯甲酸生产商在资本密集环境下维持成长所面临的挑战。
随着生产商积极推动合成路径的脱碳,以满足全球永续性要求,绿色化学製造的整合正成为主流趋势。这一转变意味着从依赖石化燃料的氧化製程转向利用可再生能源和永续原材料的低排放生产模式,从而满足製药业对环保供应链的需求。例如,朗盛在其2024年永续发展报告中将重点介绍其香精香料产品组合中的「Scopeblue」标籤系列,该标籤证明这些成分的碳足迹比传统替代品至少低50%。
同时,为降低物流脆弱性并支持区域医药中心的发展,辅料供应链的在地化正在改变市场动态。供应商正加速在高成长市场建立本土生产能力,以避免进口关税并缩短本地学名药生产商的前置作业时间。例如,科莱恩在2024年11月举行的印度国际医药产业大会(CPHI India)上发布新闻稿称,公司将推出八种本地生产的新型医药原料,直接供该地区不断扩大的学名药和生物製药生产基地。
The Global Benzoic Acid Excipient Market is projected to expand from 364.21 Thousand Tonnes in 2025 to 467.53 Thousand Tonnes by 2031, achieving a CAGR of 4.25%. This excipient serves as a vital pharmaceutical component, acting primarily as an antimicrobial preservative to suppress fungal and bacterial proliferation in semi-solid and liquid formulations, while also functioning as a pH adjuster and tablet lubricant in diverse topical and oral medicines. Market growth is largely bolstered by the accelerating global production of generic drugs, which necessitates cost-effective preservation solutions to ensure product stability across extended supply chains, alongside the rising prevalence of dermatological conditions that demand the robust antifungal properties inherent to this chemical agent.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | 364.21 Thousand Tonnes |
| Market Size 2031 | 467.53 Thousand Tonnes |
| CAGR 2026-2031 | 4.25% |
| Fastest Growing Segment | Direct Sales |
| Largest Market | North America |
Despite these growth factors, the market faces significant hurdles regarding high production costs and regulatory pressures in major manufacturing hubs. Manufacturers must navigate volatile energy prices and strict compliance standards that can negatively impact operational efficiency and pricing strategies. According to the European Chemical Industry Council, in 2024, the European chemical sector reported a capacity utilization rate fluctuating around 75 percent due to high energy and regulatory costs. This underutilization illustrates the broader industrial challenge of maintaining competitiveness for essential chemical intermediates within a capital-intensive global market.
Market Driver
The expansion of the pharmaceutical manufacturing industry, particularly the surge in generic medicine production, serves as a primary catalyst for the benzoic acid excipient market. As pharmaceutical companies strive to meet the healthcare needs of growing populations while managing costs, there is a heightened reliance on established, economical preservatives that ensure formulation integrity. Benzoic acid is essential in this context, widely utilized to prevent microbial contamination in liquid orals and parenteral preparations. This manufacturing momentum is evident in key production hubs; according to the India Brand Equity Foundation's 'Pharmaceuticals Industry Report' from August 2024, India's pharmaceutical exports stood at US$ 27.9 billion in FY24, reflecting the intense scale of manufacturing activities that require consistent supplies of high-purity excipients.
Concurrently, the growing prevalence of dermatological conditions and fungal infections has amplified the requirement for specialized topical ointments and creams. Benzoic acid acts as a fungistatic agent in these applications, often combined with salicylic acid to treat ringworm and athlete's foot effectively. This demand for dermatological therapies is driving revenue growth for companies specializing in skin health, subsequently increasing the uptake of raw material ingredients. For instance, according to Beiersdorf AG's 'Annual Report 2023' released in February 2024, the Derma business unit achieved organic sales growth of 24.0 percent, highlighting the expanding consumer need for therapeutic skin products. To sustain this output, chemical suppliers are maintaining significant operational footprints, as evidenced by Lanxess generating sales of EUR 2.340 billion in its Consumer Protection segment in 2024, underscoring the sector's substantial market value.
Market Challenge
High production costs resulting from volatile energy prices and stringent regulatory standards present a substantial barrier to the expansion of the benzoic acid excipient market. Benzoic acid manufacturing is an energy-intensive process, making the sector highly vulnerable to fluctuations in global fuel and power markets. When operational expenses rise due to these external economic factors, manufacturers often struggle to maintain competitive pricing strategies essential for the generic drug industry. Consequently, producers may be forced to reduce output or delay capacity expansions to preserve margins, directly limiting the availability of this critical preservative for pharmaceutical formulations.
The impact of these cost pressures is evident in the reduced industrial output observed in major chemical manufacturing regions. This environment of elevated expenses creates a restrictive atmosphere where suppliers cannot easily scale operations to meet rising demand. According to the American Chemistry Council, in 2023, the production of basic chemicals in the United States fell by 2.5 percent as producers idled capacity to manage high inventory levels and operational costs. This contraction in the broader chemical sector reflects the direct difficulties benzoic acid manufacturers face in sustaining growth while navigating an increasingly capital-intensive landscape.
Market Trends
The Integration of Green Chemistry Manufacturing is becoming a dominant trend as producers actively decarbonize synthesis pathways to align with global sustainability mandates. This shift involves transitioning from fossil-fuel-dependent oxidation processes to low-emission production models that utilize renewable energy and sustainable raw materials, addressing the pharmaceutical industry's requirement for environmentally responsible supply chains. For instance, according to Lanxess, in 2024, in the 'Sustainability Report', the company highlighted its 'Scopeblue' label variants for the Flavors & Fragrances portfolio, certifying that these ingredients possess a carbon footprint at least 50 percent lower than conventional alternatives.
Simultaneously, the Localization of Excipient Supply Chains is reshaping market dynamics, driven by the need to mitigate logistics vulnerabilities and support regional pharmaceutical hubs. Suppliers are increasingly establishing domestic manufacturing capabilities within high-growth markets to bypass import tariffs and shorten lead times for local generic drug formulators. Evidencing this structural shift, according to Clariant, November 2024, in a press announcement at 'CPHI India', the company launched eight new locally manufactured pharmaceutical ingredients to directly serve the region's expanding generic and biologic manufacturing base.
Report Scope
In this report, the Global Benzoic Acid Excipient Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Benzoic Acid Excipient Market.
Global Benzoic Acid Excipient Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: